Different sources, same result
Numerous patients suffering from chronic liver diseases are currently receiving inadequate treatment due to the lack of organs donated for transplantation. However, hepatocytes derived from induced pluripotent stem cells (iPSCs) could offer an alternative for the future. Scientists from the Max Planck Institute for Molecular Genetics in Berlin compared hepatocytes from embryonic stem cells with hepatocytes from iPS cells and found that their gene expression is very similar. Nevertheless, in comparison to 'real' hepatocytes, just under half of the genes exhibited a different gene expression. Therefore, the gene expression of hepatocytes derived from iPS cells still requires adaptation before the cells could be used in the treatment of liver diseases...